Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nik Krajnc

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Acta Neuropathologica|September 16, 2023
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosisAnnika Hofmann, Nik Krajnc, Assunta Dal-Bianco, et al.
Annals of Clinical and Translational Neurology|December 17, 2024
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical thresholdGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 7, 2024
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining conceptGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Journal of Neurology|June 9, 2026
Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosisFabian Föttinger, Nik Krajnc, Klaus Berek, et al.
Annals of Neurology|May 28, 2026
Idiopathic Intracranial Hypertension Is Characterized by a Distinct Proteomic ProfileSantosh D Bhosale, Arkadiusz Nawrocki, Johanne J Korsbæk, et al.
Annals of Clinical and Translational Neurology|August 5, 2025
The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple SclerosisGabriel Bsteh, Ruchi Tanavade, Nik Krajnc, et al.
European Journal of Neurology|December 17, 2024
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcomeGabriel Bsteh, Robert Hoepner, Jonathan A Gernert, et al.
Frontiers in Immunology|November 24, 2025
Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosisMartin Schmidauer, Klaus Berek, Michael Auer, et al.
Neurology|August 28, 2024
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI ActivityGabriel Bsteh, Marie L Aicher, Janette F Walde, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2026
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGADThivya Pakeerathan, James Davis, Amanda D Henderson, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Acta Neuropathologica|September 16, 2023
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosisAnnika Hofmann, Nik Krajnc, Assunta Dal-Bianco, et al.
Annals of Clinical and Translational Neurology|December 17, 2024
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical thresholdGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 7, 2024
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining conceptGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Journal of Neurology|June 9, 2026
Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosisFabian Föttinger, Nik Krajnc, Klaus Berek, et al.
Annals of Neurology|May 28, 2026
Idiopathic Intracranial Hypertension Is Characterized by a Distinct Proteomic ProfileSantosh D Bhosale, Arkadiusz Nawrocki, Johanne J Korsbæk, et al.
Annals of Clinical and Translational Neurology|August 5, 2025
The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple SclerosisGabriel Bsteh, Ruchi Tanavade, Nik Krajnc, et al.
European Journal of Neurology|December 17, 2024
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcomeGabriel Bsteh, Robert Hoepner, Jonathan A Gernert, et al.
Frontiers in Immunology|November 24, 2025
Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosisMartin Schmidauer, Klaus Berek, Michael Auer, et al.
Neurology|August 28, 2024
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI ActivityGabriel Bsteh, Marie L Aicher, Janette F Walde, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2026
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGADThivya Pakeerathan, James Davis, Amanda D Henderson, et al.
Pageof 7